Natco Pharma hikes investment in US-based eGenesis to $16.7 million
Under the revised structure, Natco Pharma (Canada) Inc will invest $13.70 million, while Natco Pharma USA LLC will contribute $3 million, according to a regulatory filing
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.